There are 2867 resources available
Welcome and Introduction
Presenter: Aleix Prat
Session: PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Resources:
Webcast
Welcome and Introduction
Presenter: Myriam Chalabi
Session: Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
Resources:
Webcast
Current Status of I-O for Treating CRC
Presenter: Myriam Chalabi
Session: Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
Resources:
Webcast
Understanding the Foundational Concepts of HER2-Low Breast Cancer: Challenges and Opportunities of an Evolving Definition
Presenter: Paolo Tarantino
Session: PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Resources:
Webcast
Treating Gastric Cancer Today: I-O-focused Update
Presenter: Kei Muro
Session: Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
Resources:
Webcast
Extending Anti-HER2 Therapy Benefits to a Larger Population of Patients: Emerging Evidence, Implementation in Clinical Practice, and Future Directions
Presenter: Shanu Modi
Session: PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Resources:
Webcast
Emerging Treatments for Esophageal Cancer: First-Line Metastatic Disease and Earlier Stages
Presenter: Emmanuelle Samalin-Scalzi
Session: Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
Resources:
Webcast
Unveiling the Biology of HER2-Low Breast Cancer: Insights From Genomics, Transcriptomics, and Opportunities With Evolving Testing Approaches
Presenter: Aleix Prat
Session: PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Resources:
Webcast
Roundtable Case Discussion, Q&A, and Summary
Presenter: Ian Chau
Session: Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
Resources:
Webcast
Exploring the Nuances of HER2-Targeted Treatment Selection for Patients With HER2-Low Breast Cancer: Expert Insights Into Implications for Practice and Team-Based Approaches to Individualizing Patient Care
Presenter: Shanu Modi
Session: PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Resources:
Webcast